XOMA Corp
NASDAQ:XOMA

Watchlist Manager
XOMA Corp Logo
XOMA Corp
NASDAQ:XOMA
Watchlist
Price: 27.13 USD 8.04% Market Closed
Market Cap: 319.6m USD
Have any thoughts about
XOMA Corp?
Write Note

P/S
Price to Sales

13.8
Current
18
Median
7.6
Industry
Lower than median
Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
13.8
=
Market Cap
318.9m USD
/
Revenue
23.1m USD
All Countries
Close
Market Cap P/S
US
XOMA Corp
NASDAQ:XOMA
318.9m USD 13.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 027 714.7
US
Abbvie Inc
NYSE:ABBV
310.3B USD 5.6
US
Amgen Inc
NASDAQ:AMGN
141.6B USD 4.4
US
Gilead Sciences Inc
NASDAQ:GILD
115.3B USD 4.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD 9.6
US
Epizyme Inc
F:EPE
94.1B EUR 1 852.6
AU
CSL Ltd
ASX:CSL
134.4B AUD 5.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD 5.6
US
Seagen Inc
F:SGT
39.3B EUR 17.8
NL
argenx SE
XBRU:ARGX
35.7B EUR 19.2
Revenue Growth P/S to Growth
US
XOMA Corp
NASDAQ:XOMA
Average P/S: 3 457 241.2
13.8
941%
0
FR
Pharnext SCA
OTC:PNEXF
38 027 714.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.6
34%
0.3
US
E
Epizyme Inc
F:EPE
1 852.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.2
220%
0.1

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
11
2-Years Forward
P/S
8.6
3-Years Forward
P/S
6.4

See Also

Discover More